|
|
Biomarkers of Inflammation, Neurodegeneration and Age-Associated Cognitive Impairment |
| 1K01AG078407-01 |
|
NIA |
2022 |
|
|
Delineating how epigenetic regulation of ACVR1C contributes to age and AD-related memory impairments in females and males |
| 1K99AG078501-01 |
|
NIA |
2022 |
|
|
The effects of long-term locus coeruleus stimulation on amyloid/tau pathology, synaptic plasticity, and memory during Alzheimers disease progression |
| 1R01AG075114-01 |
|
NIA |
2022 |
|
|
Age-related Hypertension and Vascular Cognitive Impairment |
| 1R01AG075963-01 |
|
NIA |
2022 |
|
|
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimers Disease |
| 1R01AG076704-01 |
|
NIA |
2022 |
|
|
Hippocampal neurogenesis in cognitive function and dysfunction in Alzheimers disease. |
| 1R01AG076940-01 |
|
NIA |
2022 |
|
|
The role of hearing loss in cognitive impairment and Alzheimer’s disease pathology |
| 1R01AG078132-01 |
|
NIA |
2022 |
|
|
Deep brain stimulation of the Nucleus Basalis of Meynert: the role of stimulation parameters in neurogenesis and cognitive recovery |
| 1R03AG075637-01 |
|
NIA |
2022 |
|
|
Prefrontal neural modulation to restore cognitive deficits in an Alzheimers Disease rat model |
| 1R21AG072355-01A1 |
|
NIA |
2022 |
|
|
Creation of a monkey mini mental state exam (mMMSE) for identifying early cognitive deficits related to Alzheimer’s disease and related dementias |
| 1R61AG078471-01 |
|
NIA |
2022 |
